Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v9-EN | Version v8-FR | |
---|---|---|
Language | English | French |
Date Updated | 2020-01-28 | 2020-01-09 |
Drug Identification Number | 00452130 | 00452130 |
Brand name | NOVAMOXIN | NOVAMOXIN |
Common or Proper name | AMOXICILLIN SUSP 250MG/5ML | AMOXICILLIN SUSP 250MG/5ML |
Company Name | TEVA CANADA LIMITED | TEVA CANADA LIMITED |
Ingredients | AMOXICILLIN | AMOXICILLIN |
Strength(s) | 250MG | 250MG |
Dosage form(s) | GRANULES FOR SUSPENSION | GRANULES FOR SUSPENSION |
Route of administration | ORAL | ORAL |
Packaging size | 150ml | 150ml |
ATC code | J01CA | J01CA |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | ||
Actual start date | 2019-10-02 | 2019-10-02 |
Estimated end date | 2020-03-31 | 2020-04-30 |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | Coverage of Teva market out to end of 2019. Amoxicillin Low Sucrose (DIN 01934163 )is available in 100ml and 150ml as a substitution. | Coverage of Teva market out to end of 2019. Amoxicillin Low Sucrose (DIN 01934163 )is available in 100ml and 150ml as a substitution. |
Health Canada comments |